Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
AbbVie
Pharma
AbbVie scores FDA green light for another ImmunoGen asset
AbbVie's ImmunoGen buyout continues to pay off, thanks to a new FDA nod for an antibody-drug conjugate for a rare form of blood cancer.
Fraiser Kansteiner
May 28, 2026 7:27am
AbbVie trims Allergan workforce by 85
May 22, 2026 12:12pm
AbbVie, GSK race up patient reputation leaderboard in the UK
May 22, 2026 9:16am
Led by Lilly, 8 companies reach double-digit revenue gains in Q1
May 21, 2026 9:00am
UCB shares results for Bimzelx's PsA triumph over Skyrizi
May 19, 2026 11:27am
AbbVie’s Skyrizi retakes top spot in April ad spend rankings
May 8, 2026 10:03am